MBP metabolic pharmaceuticals limited

If the results were no good, you wouldnt expect them to go to...

  1. 183 Posts.
    lightbulb Created with Sketch. 14
    If the results were no good, you wouldnt expect them to go to the trouble of getting independent opinion......would u?

    Also don't know why they would continue with "Progression of an oral version of ACV1 into formal preclinical development " if results of current testing were not positive.

    Still has promise.....but as they say high risk.....should be high reward.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.